Brutonˈs tyrosine kinase—an integral protein of B cell development that also has an essential role in the innate immune system

Btk is the protein affected in XLA, a disease identified as a B cell differentiation defect. Btk is crucial for B cell differentiation and activation, but its role in other cells is not fully understood. This review focuses on the function of Btk in monocytes, neutrophils, and platelets and the receptors and signaling cascades in such cells with which Btk is associated.

[1]  K. Fiedler,et al.  MyD88 is involved in myeloid as well as lymphoid hematopoiesis independent of the presence of a pathogen. , 2013, American journal of blood research.

[2]  T. Standiford,et al.  Bruton's tyrosine kinase mediates FcγRIIa/Toll-like receptor-4 receptor crosstalk in human neutrophils. , 2013, American journal of respiratory cell and molecular biology.

[3]  Seng-Lai Tan,et al.  Bruton's Tyrosine Kinase mediates platelet receptor-induced generation of microparticles: a potential mechanism for amplification of inflammatory responses in rheumatoid arthritis synovial joints. , 2013, Immunology letters.

[4]  L. Santos‐Argumedo,et al.  Increased Pro-inflammatory Cytokine Production After Lipopolysaccharide Stimulation in Patients with X-linked Agammaglobulinemia , 2012, Journal of Clinical Immunology.

[5]  Y. Lau,et al.  Tyrosine Kinase Btk Is Required for NK Cell Activation , 2012, The Journal of Biological Chemistry.

[6]  L. Santos‐Argumedo,et al.  Consequences of two naturally occurring missense mutations in the structure and function of Bruton agammaglobulinemia tyrosine kinase , 2012, IUBMB life.

[7]  A. Zarbock,et al.  The Role of the Tec Kinase Bruton's Tyrosine Kinase (Btk) in Leukocyte Recruitment , 2012, International reviews of immunology.

[8]  H. Kanegane,et al.  The kinase Btk negatively regulates the production of reactive oxygen species and stimulation-induced apoptosis in human neutrophils , 2012, Nature Immunology.

[9]  A. Zarbock,et al.  Crucial role of SLP-76 and ADAP for neutrophil recruitment in mouse kidney ischemia-reperfusion injury , 2012, The Journal of experimental medicine.

[10]  Y. Lau,et al.  Dendritic and T Cell Response to Influenza is Normal in the Patients with X-Linked Agammaglobulinemia , 2012, Journal of Clinical Immunology.

[11]  M. Nelson,et al.  Calcium signaling in smooth muscle. , 2011, Cold Spring Harbor perspectives in biology.

[12]  Pradip Sen,et al.  A Novel Role for Bruton's Tyrosine Kinase in Hepatocyte Growth Factor-mediated Immunoregulation of Dendritic Cells* , 2011, The Journal of Biological Chemistry.

[13]  D. Wagner,et al.  How platelets safeguard vascular integrity , 2011, Journal of thrombosis and haemostasis : JTH.

[14]  L. Bullinger,et al.  Neutrophil development and function critically depend on Bruton tyrosine kinase in a mouse model of X-linked agammaglobulinemia. , 2011, Blood.

[15]  N. Horwood,et al.  Elevated cytokine production restores bone resorption by human Btk‐deficient osteoclasts , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  C. Cunningham-Rundles,et al.  TLR signaling and effector functions are intact in XLA neutrophils. , 2010, Clinical immunology.

[17]  B. Vanhaesebroeck,et al.  Btk-dependent Rac activation and actin rearrangement following FcεRI aggregation promotes enhanced chemotactic responses of mast cells , 2010, Journal of Cell Science.

[18]  K. Ley,et al.  Tyrosine kinase Btk regulates E-selectin-mediated integrin activation and neutrophil recruitment by controlling phospholipase C (PLC) gamma2 and PI3Kgamma pathways. , 2010, Blood.

[19]  M. Conley.  Genetics of hypogammaglobulinemia: what do we really know? , 2009, Current opinion in immunology.

[20]  M. van der Burg,et al.  Genetic and demographic features of X-linked agammaglobulinemia in Eastern and Central Europe: a cohort study. , 2009, Molecular immunology.

[21]  Mauno Vihinen,et al.  Bruton’s tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain , 2009, Immunological reviews.

[22]  H. Kanegane,et al.  Neutropenia associated with X-linked Agammaglobulinemia in an Iranian referral center. , 2009, Iranian journal of allergy, asthma, and immunology.

[23]  Taesoo Kim,et al.  The Tec Family Tyrosine Kinase Btk Regulates RANKL-induced Osteoclast Maturation* , 2008, Journal of Biological Chemistry.

[24]  T. Kodama,et al.  Tyrosine Kinases Btk and Tec Regulate Osteoclast Differentiation by Linking RANK and ITAM Signals , 2008, Cell.

[25]  J. A. Linton,et al.  Analysis of Clinical Presentations of Bruton Disease: A Review of 20 Years of Accumulated Data from Pediatric Patients at Severance Hospital , 2008, Yonsei medical journal.

[26]  H. Kanegane,et al.  Toll-like receptor signaling is impaired in dendritic cells from patients with X-linked agammaglobulinemia. , 2008, Clinical immunology.

[27]  L. Santos‐Argumedo,et al.  Characterization of Bruton's tyrosine kinase mutations in Mexican patients with X-linked agammaglobulinemia. , 2008, Molecular immunology.

[28]  C. Feighery,et al.  Signaling by Toll-like Receptors 8 and 9 Requires Bruton's Tyrosine Kinase* , 2007, Journal of Biological Chemistry.

[29]  R. Küppers,et al.  CD303 (BDCA‐2) signals in plasmacytoid dendritic cells via a BCR‐like signalosome involving Syk, Slp65 and PLCγ2 , 2007, European journal of immunology.

[30]  Jessica M. Lindvall,et al.  Defective Toll‐like receptor 9‐mediated cytokine production in B cells from Bruton's tyrosine kinase‐deficient mice , 2007, Immunology.

[31]  P. Schwartzberg,et al.  Tec kinases, actin, and cell adhesion , 2007, Immunological reviews.

[32]  R. Joseph,et al.  A remote substrate docking mechanism for the tec family tyrosine kinases. , 2007, Biochemistry.

[33]  A. Šedivá,et al.  Impaired Toll-like receptor 8-mediated IL-6 and TNF-alpha production in antigen-presenting cells from patients with X-linked agammaglobulinemia. , 2007, Blood.

[34]  M. Vihinen,et al.  BTKbase: the mutation database for X‐linked agammaglobulinemia , 2006, Human mutation.

[35]  A. Salavati,et al.  Clinical, Immunological and Molecular Characteristics of 37 Iranian Patients with X-Linked Agammaglobulinemia , 2006, International Archives of Allergy and Immunology.

[36]  S. Tzeng,et al.  Solution structure and phosphopeptide binding of the SH2 domain from the human Bruton’s tyrosine kinase , 2006, Journal of biomolecular NMR.

[37]  C. Cunningham-Rundles,et al.  X-Linked Agammaglobulinemia: Report on a United States Registry of 201 Patients , 2006, Medicine.

[38]  Paul J Hertzog,et al.  Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation , 2006, Nature Immunology.

[39]  M. Croft,et al.  Regulation of dendritic cell maturation and function by Bruton's tyrosine kinase via IL-10 and Stat3. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[40]  H. Kanegane,et al.  Severe Neutropenia in Japanese Patients with X-Linked Agammaglobulinemia , 2005, Journal of Clinical Immunology.

[41]  Jessica M. Lindvall,et al.  Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling , 2005, Immunological reviews.

[42]  S. Shurtleff,et al.  Genetic analysis of patients with defects in early B‐cell development , 2005, Immunological reviews.

[43]  G. Koretzky,et al.  The SLP-76 family of adapter proteins. , 2004, Seminars in immunology.

[44]  J. Gibbins.  Platelet adhesion signalling and the regulation of thrombus formation , 2004, Journal of Cell Science.

[45]  M. Farrar,et al.  STAT5 Activation Underlies IL7 Receptor-Dependent B Cell Development1 , 2004, The Journal of Immunology.

[46]  Leo D. Wang,et al.  B‐cell antigen‐receptor signalling in lymphocyte development , 2003, Immunology.

[47]  R. Hendriks,et al.  The B Cell Antigen Receptor Controls Integrin Activity through Btk and PLCγ2 , 2003, The Journal of experimental medicine.

[48]  S. Watson,et al.  Tec regulates platelet activation by GPVI in the absence of Btk. , 2003, Blood.

[49]  T. Wirth,et al.  Bruton's Tyrosine Kinase Is a Toll/Interleukin-1 Receptor Domain-binding Protein That Participates in Nuclear Factor κB Activation by Toll-like Receptor 4* , 2003, Journal of Biological Chemistry.

[50]  C. Cancrini,et al.  Bruton's tyrosine kinase defect in dendritic cells from X‐linked agammaglobulinaemia patients does not influence their differentiation, maturation and antigen‐presenting cell function , 2003, Clinical and experimental immunology.

[51]  H. Mano,et al.  Bruton's Tyrosine Kinase Is Required For Lipopolysaccharide-induced Tumor Necrosis Factor α Production , 2003, The Journal of experimental medicine.

[52]  S. Bourgoin,et al.  Chemotactic Factor-Induced Recruitment and Activation of Tec Family Kinases in Human Neutrophils. II. Effects of LFM-A13, a Specific Btk Inhibitor1 , 2003, The Journal of Immunology.

[53]  L. Notarangelo,et al.  Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. , 2002, Clinical immunology.

[54]  W. Birchmeier,et al.  The impact of c‐met/scatter factor receptor on dendritic cell migration , 2002, European journal of immunology.

[55]  P. Naccache,et al.  Chemotactic Factor-induced Recruitment and Activation of Tec Family Kinases in Human Neutrophils , 2002, The Journal of Biological Chemistry.

[56]  S. Rath,et al.  Macrophage Effector Functions Controlled by Bruton’s Tyrosine Kinase Are More Crucial Than the Cytokine Balance of T Cell Responses for Microfilarial Clearance 1 , 2002, The Journal of Immunology.

[57]  F. Uckun,et al.  Crystal Structure of Bruton's Tyrosine Kinase Domain Suggests a Novel Pathway for Activation and Provides Insights into the Molecular Basis of X-linked Agammaglobulinemia* , 2001, The Journal of Biological Chemistry.

[58]  J. Kinet,et al.  Interaction between the Btk PH Domain and Phosphatidylinositol-3,4,5-trisphosphate Directly Regulates Btk* , 2001, The Journal of Biological Chemistry.

[59]  M. Vihinen,et al.  The Tec family of cytoplasmic tyrosine kinases: mammalian Btk, Bmx, Itk, Tec, Txk and homologs in other species , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[60]  T. Miyawaki,et al.  Recurrent pneumonia with mild hypogammaglobulinemia diagnosed as X-linked agammaglobulinemia in adults , 2001, Respiratory research.

[61]  A. Satterthwaite,et al.  The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspective. , 2000, Immunological reviews.

[62]  H. Kanegane,et al.  Atypical X-linked agammaglobulinemia diagnosed in three adults. , 1999, Internal medicine.

[63]  P. Várnai,et al.  Phosphatidylinositol 3-Kinase-dependent Membrane Association of the Bruton’s Tyrosine Kinase Pleckstrin Homology Domain Visualized in Single Living Cells* , 1999, The Journal of Biological Chemistry.

[64]  S. Pillai,et al.  Accelerated emigration of B lymphocytes in the Xid mouse. , 1999, Journal of immunology.

[65]  Mohamed,et al.  Signalling of Bruton's Tyrosine Kinase, Btk , 1999, Scandinavian journal of immunology.

[66]  S. Watson,et al.  A role for Bruton's tyrosine kinase (Btk) in platelet activation by collagen , 1998, Current Biology.

[67]  T. Adachi,et al.  The mechanism of IL-5 signal transduction. , 1998, The American journal of physiology.

[68]  H. Takayama,et al.  Physical and Functional Association of the Src Family Kinases Fyn and Lyn with the Collagen Receptor Glycoprotein Vi-fc Receptor ␥ Chain Complex on Human Platelets , 1998 .

[69]  M. Vihinen,et al.  Solution structure of the SH3 domain from Bruton's tyrosine kinase. , 1998, Biochemistry.

[70]  M. Saraste,et al.  Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X‐linked agammaglobulinaemia , 1997, The EMBO journal.

[71]  J. Rohrer,et al.  Neutropenia in X-linked agammaglobulinemia. , 1996, Clinical immunology and immunopathology.

[72]  F. Grosveld,et al.  Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre‐B cell stage. , 1996, The EMBO journal.

[73]  C. Ware,et al.  Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice , 1994, The Journal of experimental medicine.

[74]  D. Adams,et al.  Hepatocyte growth factor and macrophage inflammatory protein 1 beta: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[75]  J. V. van Dongen,et al.  The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages , 1993, European journal of immunology.

[76]  D J Rawlings,et al.  Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. , 1993, Science.

[77]  Ornella Parolini,et al.  Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia , 1993, Cell.

[78]  C. Chiu,et al.  Differential roles of stromal cells, interleukin-7, and kit-ligand in the regulation of B lymphopoiesis. , 1992, Blood.

[79]  K. Zsebo,et al.  The role of recombinant stem cell factor in early B cell development. Synergistic interaction with IL-7. , 1991, Journal of immunology.

[80]  M. Cooper,et al.  Circulating B-cells in patients with immunodeficiency. , 1972, The American journal of pathology.

[81]  C. Cunningham-Rundles,et al.  Toll-like receptor 4-, 7-, and 8-activated myeloid cells from patients with X-linked agammaglobulinemia produce enhanced inflammatory cytokines. , 2012, The Journal of allergy and clinical immunology.

[82]  L. Samelson.  Immunoreceptor signaling. , 2011, Cold Spring Harbor perspectives in biology.

[83]  Tong-Xin Chen,et al.  Clinical Characteristics and Genotype-phenotype Correlation in 62 Patients with X-linked Agammaglobulinemia , 2009, Journal of Clinical Immunology.

[84]  S. Rosenzweig,et al.  Clinical and Molecular Analysis of 49 Patients With X-linked Agammaglobulinemia From A Single Center in Argentina , 2008, Journal of Clinical Immunology.

[85]  D. Gorter.  Bruton’s Tyrosine Kinase and Phospholipase C 2 Mediate Chemokine-Controlled B Cell Migration and Homing , 2008 .

[86]  R. Hendriks,et al.  Bruton's tyrosine kinase and phospholipase Cgamma2 mediate chemokine-controlled B cell migration and homing. , 2007, Immunity.

[87]  M. Kaplan,et al.  Bruton’s Tyrosine Kinase Is Required for TLR-Induced IL-10 Production , 2006 .

[88]  A. Minty,et al.  Function of the interleukin-2 (IL-2) receptor gamma-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15. , 1995, Blood.

[89]  D. Vetrie,et al.  The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases , 1993, Nature.